In 2022, Stephen H. Rusckowski earned $9.95M in total compensation at Quest Diagnostics, including $1.28M salary and $8.35M in stock. Most recently acquired 5,952 shares in May 2024. Currently holds stock worth $79.60M. Led Quest Diagnostics as CEO for 10 years.
Compensation History
Annual executive compensation data for Stephen H. Rusckowski, including salary, bonuses, and stock awards.
Year
2022
Total Compensation
$9.95M
Salary
$1.28M
Bonus
$0.00
Other
$317.17K
Salary
$1.28MBoard Justification
The compensation philosophy is designed to align executive compensation with the Company’s performance, focusing on both financial and non-financial results, and individual performance.
Bonus
$0.00Board Justification
No bonus was awarded in 2022.
Other Compensation
$317.17KBoard Justification
Includes matching contributions under the 401(k) Plan, matching credits under the SDCP, personal ground transportation, use of company aircraft, and executive physical.
Restricted Stock
Board Justification
The value of the stock awards that vested in 2022, including performance shares and RSUs.
Performance Metrics
Performance metrics include adjusted diluted EPS, base business revenue attainment, medical quality, customer experience, employee engagement, and COVID-19 response.
Stephen H. Rusckowski
Ex-CEO of Quest Diagnostics
Sector of Economy
Healthcare
Born
July 30, 2024 - 1 years ago
CEO of Quest Diagnostics for
10 years 6 months (Apr 2012 - Nov 2022)
Previous Experience
Unknown
Other Quest Diagnostics CEOs
Holdings
Track Stephen H. Rusckowski's stock holdings and portfolio value over time.
Total Stock Sold
$203.13M
$203.13M
1,688,257 DGX shares
What if they kept their stock?
If Stephen H. Rusckowski didn't sell their stock, today they would have:
Extra DGX1,688,257 shares worth $308.12M.
This is 51.69% and $104.99M more than what they got when they sold the stock.
Insider Trading
Stephen H. Rusckowski's recent stock transactions, purchases, and sales filed with the SEC.
5,952 shares
BAX
May 7, 2024
Received
3,049 shares
BAX
Aug 21, 2023
Received
$12.22M
DGX at $147.86/share
Mar 6, 2023
Received
20,059 shares
DGX
Feb 23, 2023
Received
$3.52M
DGX at $141.36/share
May 25, 2022
Sale
$50.74M
DGX at $141.00/share
May 23, 2022
Sale
$9.13M
DGX at $130.09/share
Mar 7, 2022
Received
22,510 shares
DGX
Feb 24, 2022
Received
$20.99M
DGX at $140.65/share
Jul 28, 2021
Sale
$5.40M
DGX at $140.02/share
Jul 26, 2021
Sale
Rivals
Compare Stephen H. Rusckowski with competitor CEOs and industry peers.
August J. Troendle
Founder and CEO of Medpace Holdings, Inc.
2023 Compensation
Stock
$0.00
Salary
$825.00K
Bonus
$814.42K
Other
$17.33K
Total Holdings
$513.58M
Stanley M. Bergman
CEO of Henry Schein
2023 Compensation
Stock
$0.00
Salary
$1.63M
Bonus
$643.65K
Other
$341.74K
Total Holdings
$49.43M
Adam H. Schechter
CEO of Labcorp Holdings
2023 Compensation
Stock
$750.00K
Salary
$1.20M
Bonus
$300.00K
Other
$150.00K
Total Holdings
$91.43M